Latest filing published 12 Mar 2021 for Oxford Immunotec Global PLC, €1.1M.
No signal scores available.
All filings by Matthew T. E. McLaughlin on record concern Oxford Immunotec Global PLC. The record holds 3 filings, for trades running from 8 April 2019 to 8 March 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 12 March 2021 came the latest disclosure, a transaction for €1.1M in Oxford Immunotec Global PLC. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations